Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$99.8K Buy
844
+201
+31% +$23.2K 0.07% 102
2026
Q1
$76.8K Hold
643
0.07% 108
2025
Q4
$87.6K Buy
+643
New +$92.5K 0.08% 111

Other funds holding XYL

Dara Capital US's XYL Position: Q2 2026 in Review

Dara Capital US increased its Xylem (XYL) stake by 31% in Q2 2026, buying an estimated $23.2K and bringing the position to 844 shares worth $99.8K. The position accounts for 0.07% of the portfolio, ranked #102.

Dara Capital US first reported a position in XYL in Q4 2025 and has held it in 3 quarters since. 1,087 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Dara Capital US held 844 shares of Xylem worth $99.8K as of Q2 2026.
  • Dara Capital US bought 201 Xylem shares in Q2 2026, an estimated $23.2K.
  • Xylem made up 0.07% of Dara Capital US's portfolio in Q2 2026, its #102 holding.
  • Dara Capital US first reported a position in Xylem in Q4 2025 and has held it in 3 quarters since.
  • 1,087 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Dara Capital US's 13F filing for Q2 2026, filed 23 Jul 2026.